Mexico fines pharmaceutical firms for price fixing
Eli Lilly y Compania-Mexico, Laboratorios Cryopharma, Probiomed and Laboratorios Pisa conspired between 2003 and 2006 to ensure a lack of competitive bidding for contracts to sell insulin, an essential medicine in the treatment of diabetes.
For their part, Pisa, Fresenius Kabi Mexico and Baxter engaged in anti-competitive collusion in their bidding for contracts to sell injectable saline solutions from 2003 to 2006.
No comments:
Post a Comment